Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myopia | 37 | 2024 | 114 | 14.070 |
Why?
|
| Retinal Ganglion Cells | 12 | 2024 | 100 | 4.950 |
Why?
|
| Circadian Rhythm | 10 | 2023 | 34 | 4.860 |
Why?
|
| Refraction, Ocular | 23 | 2024 | 127 | 4.280 |
Why?
|
| Pupil | 14 | 2024 | 45 | 4.260 |
Why?
|
| Tomography, Optical Coherence | 17 | 2024 | 217 | 3.860 |
Why?
|
| Refractive Errors | 8 | 2025 | 58 | 3.800 |
Why?
|
| Retina | 11 | 2024 | 130 | 3.730 |
Why?
|
| Accommodation, Ocular | 15 | 2021 | 36 | 3.640 |
Why?
|
| Choroid | 11 | 2024 | 25 | 3.410 |
Why?
|
| Light | 7 | 2024 | 43 | 3.090 |
Why?
|
| Emmetropia | 8 | 2021 | 14 | 2.730 |
Why?
|
| Humans | 51 | 2025 | 4936 | 2.710 |
Why?
|
| Sleep | 7 | 2022 | 62 | 2.650 |
Why?
|
| Macaca mulatta | 16 | 2024 | 111 | 2.620 |
Why?
|
| Axial Length, Eye | 12 | 2024 | 25 | 2.170 |
Why?
|
| Child | 18 | 2025 | 627 | 2.110 |
Why?
|
| Electroretinography | 4 | 2023 | 57 | 2.040 |
Why?
|
| Biometry | 7 | 2024 | 31 | 1.950 |
Why?
|
| Optic Disk | 5 | 2024 | 59 | 1.930 |
Why?
|
| Male | 29 | 2025 | 2491 | 1.910 |
Why?
|
| Animals | 28 | 2024 | 1711 | 1.900 |
Why?
|
| Adult | 20 | 2024 | 1567 | 1.730 |
Why?
|
| Young Adult | 15 | 2024 | 787 | 1.650 |
Why?
|
| Intraocular Pressure | 5 | 2023 | 62 | 1.590 |
Why?
|
| Female | 21 | 2024 | 2523 | 1.460 |
Why?
|
| Eye | 5 | 2020 | 20 | 1.460 |
Why?
|
| Nerve Fibers | 4 | 2024 | 55 | 1.430 |
Why?
|
| Photic Stimulation | 9 | 2023 | 136 | 1.370 |
Why?
|
| Lighting | 3 | 2020 | 9 | 1.370 |
Why?
|
| Adolescent | 11 | 2025 | 758 | 1.180 |
Why?
|
| Optic Nerve Injuries | 2 | 2020 | 6 | 1.170 |
Why?
|
| Mydriatics | 3 | 2020 | 11 | 1.100 |
Why?
|
| Lens, Crystalline | 6 | 2014 | 34 | 1.100 |
Why?
|
| Environmental Exposure | 2 | 2018 | 10 | 1.060 |
Why?
|
| Hyperopia | 6 | 2025 | 15 | 1.060 |
Why?
|
| Wearable Electronic Devices | 3 | 2022 | 17 | 1.030 |
Why?
|
| Bruch Membrane | 4 | 2023 | 19 | 1.020 |
Why?
|
| Reflex, Pupillary | 3 | 2021 | 4 | 0.990 |
Why?
|
| Melatonin | 4 | 2019 | 12 | 0.990 |
Why?
|
| Jews | 2 | 2023 | 2 | 0.960 |
Why?
|
| Cornea | 2 | 2024 | 140 | 0.890 |
Why?
|
| Retinal Vessels | 2 | 2024 | 16 | 0.890 |
Why?
|
| Interferometry | 2 | 2022 | 6 | 0.870 |
Why?
|
| Microvessels | 1 | 2024 | 6 | 0.870 |
Why?
|
| Seasons | 3 | 2020 | 9 | 0.850 |
Why?
|
| Phenylephrine | 2 | 2020 | 4 | 0.850 |
Why?
|
| Tonometry, Ocular | 2 | 2022 | 39 | 0.830 |
Why?
|
| Rod Opsins | 2 | 2021 | 3 | 0.820 |
Why?
|
| Exercise | 2 | 2023 | 173 | 0.810 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 225 | 0.810 |
Why?
|
| Anterior Eye Segment | 3 | 2022 | 12 | 0.810 |
Why?
|
| Color Vision | 1 | 2023 | 11 | 0.780 |
Why?
|
| Reading | 2 | 2021 | 74 | 0.780 |
Why?
|
| Chickens | 2 | 2020 | 22 | 0.770 |
Why?
|
| Anesthesia | 1 | 2022 | 1 | 0.770 |
Why?
|
| Ketamine | 1 | 2022 | 3 | 0.770 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2022 | 9 | 0.760 |
Why?
|
| Atropine | 3 | 2023 | 9 | 0.740 |
Why?
|
| Guinea Pigs | 5 | 2021 | 10 | 0.710 |
Why?
|
| Visual Perception | 1 | 2022 | 57 | 0.690 |
Why?
|
| Distance Perception | 1 | 2020 | 3 | 0.670 |
Why?
|
| Optometry | 1 | 2020 | 14 | 0.650 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 50 | 0.650 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 258 | 0.640 |
Why?
|
| Child, Preschool | 5 | 2025 | 180 | 0.620 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2019 | 6 | 0.610 |
Why?
|
| Posterior Eye Segment | 1 | 2018 | 3 | 0.580 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2018 | 2 | 0.570 |
Why?
|
| Sunlight | 1 | 2018 | 3 | 0.560 |
Why?
|
| Pilocarpine | 3 | 2014 | 3 | 0.550 |
Why?
|
| Anterior Chamber | 3 | 2022 | 7 | 0.540 |
Why?
|
| Miotics | 3 | 2007 | 3 | 0.540 |
Why?
|
| Models, Animal | 3 | 2023 | 24 | 0.510 |
Why?
|
| Visual Acuity | 5 | 2025 | 179 | 0.510 |
Why?
|
| Optic Nerve | 1 | 2016 | 9 | 0.500 |
Why?
|
| Pattern Recognition, Visual | 1 | 2016 | 28 | 0.490 |
Why?
|
| Deep Brain Stimulation | 2 | 2007 | 15 | 0.480 |
Why?
|
| Collagen | 1 | 2015 | 34 | 0.470 |
Why?
|
| Ciliary Body | 2 | 2006 | 2 | 0.460 |
Why?
|
| Middle Aged | 5 | 2023 | 967 | 0.460 |
Why?
|
| Glaucoma | 1 | 2015 | 40 | 0.450 |
Why?
|
| Muscarinic Agonists | 1 | 2014 | 1 | 0.440 |
Why?
|
| Presbyopia | 2 | 2004 | 5 | 0.430 |
Why?
|
| Saliva | 3 | 2019 | 19 | 0.420 |
Why?
|
| Risk Factors | 3 | 2023 | 159 | 0.400 |
Why?
|
| Time Factors | 3 | 2019 | 163 | 0.400 |
Why?
|
| Israel | 5 | 2025 | 5 | 0.390 |
Why?
|
| Vision Tests | 3 | 2023 | 50 | 0.380 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2023 | 21 | 0.380 |
Why?
|
| Muscarinic Antagonists | 2 | 2020 | 18 | 0.370 |
Why?
|
| Lasers | 2 | 2024 | 9 | 0.350 |
Why?
|
| Blood Pressure | 2 | 2023 | 40 | 0.350 |
Why?
|
| Carbachol | 3 | 2006 | 8 | 0.340 |
Why?
|
| Prevalence | 4 | 2025 | 66 | 0.340 |
Why?
|
| Ultrasonography | 4 | 2022 | 20 | 0.330 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 269 | 0.310 |
Why?
|
| Autonomic Agents | 1 | 2009 | 1 | 0.310 |
Why?
|
| Echothiophate Iodide | 1 | 2009 | 1 | 0.310 |
Why?
|
| Timolol | 1 | 2009 | 1 | 0.310 |
Why?
|
| Epinephrine | 1 | 2009 | 8 | 0.310 |
Why?
|
| Purinergic P1 Receptor Antagonists | 2 | 2021 | 4 | 0.310 |
Why?
|
| Analysis of Variance | 2 | 2019 | 70 | 0.300 |
Why?
|
| Animals, Newborn | 4 | 2021 | 31 | 0.270 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 25 | 0.260 |
Why?
|
| Fluorescein Angiography | 2 | 2024 | 11 | 0.260 |
Why?
|
| Actigraphy | 2 | 2017 | 15 | 0.260 |
Why?
|
| Oculomotor Nerve | 1 | 2006 | 4 | 0.260 |
Why?
|
| Activities of Daily Living | 2 | 2018 | 46 | 0.250 |
Why?
|
| Electrodes, Implanted | 4 | 2007 | 11 | 0.240 |
Why?
|
| Pirenzepine | 1 | 2004 | 2 | 0.220 |
Why?
|
| Tissue Expansion | 1 | 2004 | 1 | 0.220 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 137 | 0.220 |
Why?
|
| Ophthalmic Solutions | 2 | 2020 | 7 | 0.210 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2004 | 20 | 0.210 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 2 | 2020 | 2 | 0.210 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 24 | 0.210 |
Why?
|
| Pandemics | 2 | 2021 | 73 | 0.210 |
Why?
|
| Muscle, Smooth | 1 | 2004 | 2 | 0.210 |
Why?
|
| Fovea Centralis | 2 | 2024 | 29 | 0.210 |
Why?
|
| Environment | 1 | 2023 | 7 | 0.200 |
Why?
|
| Administration, Ophthalmic | 2 | 2021 | 3 | 0.200 |
Why?
|
| Sclera | 1 | 2004 | 57 | 0.200 |
Why?
|
| Acepromazine | 1 | 2022 | 1 | 0.190 |
Why?
|
| Dilatation | 1 | 2022 | 1 | 0.190 |
Why?
|
| Parents | 1 | 2023 | 58 | 0.190 |
Why?
|
| Iris | 3 | 2009 | 10 | 0.190 |
Why?
|
| Wrist Joint | 1 | 2021 | 2 | 0.180 |
Why?
|
| Wrist | 1 | 2021 | 4 | 0.180 |
Why?
|
| Odds Ratio | 1 | 2021 | 17 | 0.180 |
Why?
|
| Judaism | 1 | 2021 | 1 | 0.180 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2023 | 78 | 0.180 |
Why?
|
| Goals | 1 | 2021 | 10 | 0.180 |
Why?
|
| Astigmatism | 1 | 2021 | 35 | 0.170 |
Why?
|
| Electrophysiology | 1 | 2021 | 24 | 0.170 |
Why?
|
| Caffeine | 1 | 2021 | 1 | 0.170 |
Why?
|
| Pilot Projects | 1 | 2021 | 98 | 0.170 |
Why?
|
| Risk Assessment | 1 | 2021 | 44 | 0.170 |
Why?
|
| Nerve Crush | 1 | 2020 | 5 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 318 | 0.160 |
Why?
|
| Corneal Topography | 2 | 2014 | 37 | 0.160 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2020 | 18 | 0.160 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2020 | 35 | 0.160 |
Why?
|
| Optics and Photonics | 1 | 2019 | 21 | 0.150 |
Why?
|
| Body Temperature | 1 | 2019 | 4 | 0.150 |
Why?
|
| Hydrocortisone | 1 | 2019 | 18 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 14 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2019 | 81 | 0.150 |
Why?
|
| Heart Rate | 1 | 2019 | 43 | 0.150 |
Why?
|
| Slit Lamp Microscopy | 1 | 2018 | 2 | 0.150 |
Why?
|
| Dark Adaptation | 1 | 2018 | 6 | 0.140 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 37 | 0.140 |
Why?
|
| Administration, Topical | 2 | 2009 | 2 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 16 | 0.140 |
Why?
|
| Vision, Ocular | 1 | 2018 | 34 | 0.140 |
Why?
|
| Iridectomy | 2 | 2009 | 2 | 0.140 |
Why?
|
| Xanthines | 1 | 2018 | 3 | 0.140 |
Why?
|
| Video Recording | 2 | 2009 | 10 | 0.140 |
Why?
|
| Anisometropia | 1 | 2018 | 7 | 0.140 |
Why?
|
| Schools | 1 | 2018 | 37 | 0.140 |
Why?
|
| RNA, Messenger | 1 | 2018 | 68 | 0.140 |
Why?
|
| Disease Progression | 3 | 2023 | 59 | 0.130 |
Why?
|
| Space Perception | 1 | 2016 | 16 | 0.120 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 8 | 0.120 |
Why?
|
| Contrast Sensitivity | 1 | 2016 | 64 | 0.120 |
Why?
|
| Cilia | 1 | 2015 | 6 | 0.120 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 5 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2015 | 23 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 17 | 0.120 |
Why?
|
| Aged | 1 | 2017 | 703 | 0.100 |
Why?
|
| Macula Lutea | 2 | 2024 | 17 | 0.090 |
Why?
|
| Adrenergic Agonists | 1 | 2009 | 2 | 0.080 |
Why?
|
| Autonomic Nervous System | 1 | 2009 | 3 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 10 | 0.080 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2009 | 20 | 0.080 |
Why?
|
| Refractometry | 1 | 2007 | 6 | 0.070 |
Why?
|
| Electric Stimulation | 1 | 2006 | 21 | 0.060 |
Why?
|
| Movement | 1 | 2006 | 52 | 0.060 |
Why?
|
| Eye Movements | 1 | 2006 | 44 | 0.060 |
Why?
|
| Mesencephalon | 1 | 2005 | 9 | 0.060 |
Why?
|
| Amblyopia | 1 | 2025 | 17 | 0.060 |
Why?
|
| Injections | 1 | 2004 | 9 | 0.050 |
Why?
|
| Conjunctiva | 1 | 2004 | 13 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2004 | 11 | 0.050 |
Why?
|
| Tissue Expansion Devices | 1 | 2004 | 1 | 0.050 |
Why?
|
| Vision Disorders | 1 | 2025 | 43 | 0.050 |
Why?
|
| Eye Color | 1 | 2004 | 2 | 0.050 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 11 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2004 | 2 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 10 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 6 | 0.040 |
Why?
|
| Global Health | 1 | 2021 | 3 | 0.040 |
Why?
|
| Educational Status | 1 | 2021 | 29 | 0.040 |
Why?
|
| Eyeglasses | 1 | 2021 | 30 | 0.040 |
Why?
|
| Ophthalmoscopy | 1 | 2020 | 10 | 0.040 |
Why?
|
| Capillaries | 1 | 2020 | 8 | 0.040 |
Why?
|
| Ophthalmoscopes | 1 | 2020 | 11 | 0.040 |
Why?
|
| Students | 1 | 2021 | 120 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2021 | 341 | 0.040 |
Why?
|
| Internationality | 1 | 2019 | 6 | 0.040 |
Why?
|
| Retinoscopy | 1 | 2018 | 6 | 0.040 |
Why?
|
| Corneal Pachymetry | 1 | 2018 | 7 | 0.040 |
Why?
|
| Sensory Deprivation | 1 | 2018 | 8 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2019 | 75 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2018 | 33 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2015 | 1 | 0.030 |
Why?
|
| Trachea | 1 | 2015 | 1 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 5 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2015 | 127 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2015 | 140 | 0.030 |
Why?
|
| Automation | 1 | 2007 | 13 | 0.020 |
Why?
|
| Lenses | 1 | 2007 | 6 | 0.020 |
Why?
|
| Calibration | 1 | 2007 | 9 | 0.020 |
Why?
|